IRS2 and metabolic dysfunction-associated steatotic liver disease: Subsequently, based on the results of LASSO and SVM-RFE, we gained two shared biomarkers (NCAPH and IRS2) in obesity and NAFLD, and IRS2 was down-regulated and NCAPH was up-regulated in disease (obesity/NAFLD) samples.